Portfolio by
Johnny Rice
2026 portfolio by
Johnny Rice
· Live scientific informatics demos.
2026 portfolio project by
Johnny Rice
. Live ChEMBL, UniProt, AACT SQL, and scientific informatics demos.
Informatics demo
ClariTrial
AI Clinical Trial Intelligence
Explore
Visualizations
Companies
Informatics
Résumé
Saved
Live data
Parsing your search query…
Explore
/
CDK2 inhibitor breast cancer HR-positive cell cycle
Search
Status
Recruiting
Active
Not Yet
Completed
Terminated
Phase
Early Ph 1
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Clear filters
Pre-filtered to show active, later-stage trials with the strongest clinical signal.
1
results for
“CDK2 inhibitor breast cancer HR-positive cell cycle”
· Phase 2
· Phase 1
NCT05905341
Withdrawn
Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.
Phase 1
Breast Cancer
Ovarian Cancer
Liposarcoma
PF-07224826
Fulvestrant
PF-07224826
+11 more
Pfizer
0
Completes Apr 2026
More detail
CT.gov
Full analysis →
Previous
1–1 of 1
Next